By Alan Rosenhoch, Buffalo Niagara Enterprise
November 12, 2014
The inaugural edition of the world’s largest business idea competition, 43North, has come to a resounding close and 11 winners will now call Buffalo their home. It should come as no surprise that the life sciences industry is very well represented among the winning companies, with more than half operating in this burgeoning sector. With our wealth of industry assets and the growth of the Buffalo Niagara Medical Campus, it’s clear why so many biotech and medical device companies are looking to Buffalo Niagara as a great region in which to grow their business. The region’s rich history of innovation was also showcased during 43North, with the premier of this fantastic new video: Next Things Now.
To earn their capital, each of these companies must establish a major operation in the Buffalo area for at least 12 months. They will all receive free incubator space, guidance from mentors related to their field and access to other exciting incentive programs (such as START-UP NY).
Let’s take a look at how the newest members of Buffalo’s life sciences community fared.
Three of the six life sciences companies impressed the panel of esteemed judges enough to earn them $500,000 each! They are: Eulysis UK, Medical Conservation Devices and Raland Therapeutics. Three more finalists took home a cool $250,000: Asana Medical, Genetisis and HemoGenyx. Additionally, Genetisis was selected as the People’s Choice Award winner, earning an additional $10,000, selected via interaction on Twitter.
Additional information on each of the winners:
Hometown: Edinburgh, Scotland
Eulysis UK is a groundbreaking development company focused and committed to optimizing pharmaceutical access globally. In collaboration with the World Health Organization, Gates Foundation and other major institutions, Eulysis UK intends to commercialize the SVS technology on a global scale to provide expanded access to life-saving medicines.
Medical Conservation Devices
Hometown: Batavia, NY
Based on an exclusively licensed patent portfolio from the University of Buffalo, Medical Conservation Deviceshas developed a low-cost anesthesia machine to expand the use of anesthesia globally, including in later approvals to sedate critically ill patients and provide anesthesia to up to 8 patients at one time.
Hometown: Fairport, NY
Raland Therapeutics is a development-stage bio-device company focused on implantable biosensors. The company’s CytoComm™ Biosensor is a real-time monitoring system, which uses living cells to “read” a patient’s physiologic response to chemotherapy. The system also allows the personalization of dosing strategies to reduce the toxicity that so often impacts one’s quality of life.
Hometown: Miami Lakes, FL
Asana Medical seeks to improve the quality of one’s health and therefore quality of life by providing a novel treatment for debilitating digestive diseases with a patent-pending medical device that stimulates the body to heal itself. Asana Medical offers a drug-free, surgery-free twist on a proven therapy and targets the $9 billion ulcerative colitis market.
Prizes: $250,000, People’s Choice Award
Hometown: Mason, OH
Genetesis is a biotechnology company oriented towards optimizing drug design for treatment of heart rhythm disorders by applying novel algorithms that analyze real-time functional heart electrophysiology. Using a patent-pending system, including a non-invasive sensor array and powerful software, Genetesis is able to quantify responsiveness to drugs before they are administered.
Hometown: New York, NY
HemoGenyx is a biotechnology company developing a revolutionary new treatment for blood diseases, such as leukemia and lymphoma. The company leverages a special class of cells, which can generate cancer-free blood stem cells. HemoGenyx’s therapy can dramatically increase the efficacy of bone marrow transplants and eliminate the need for donors.